Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Prognostic Value of High-sensitive Troponin T for Predicting Cardiovascular Events after Atrial Fibrillation Ablation.

Tamura S, Doi A, Matsuo M, Katayama H, Yoshiyama T, Tatsumi H, Izumiya Y, Yoshiyama M.

J Cardiovasc Electrophysiol. 2019 Jun 13. doi: 10.1111/jce.14032. [Epub ahead of print]

PMID:
31192482
2.

Multiple coronary artery spasms triggering life-threatening ventricular arrhythmia associated with the radiofrequency ablation of ganglionated plexuses of the left atrium.

Sakamoto S, Kataoka T, Kanai M, Tamura K, Iguchi T, Tatsumi H, Doi A, Yoshiyama M.

J Cardiol Cases. 2018 Jan 17;17(4):133-136. doi: 10.1016/j.jccase.2017.12.004. eCollection 2018 Apr.

3.

Diagnostic value of electrocardiographic P-wave characteristics in atrial fibrillation recurrence and tachycardia-induced cardiomyopathy after catheter ablation.

Doi A, Takagi M, Katayama H, Yoshiyama T, Hayashi Y, Tatsumi H, Yoshiyama M.

Heart Vessels. 2018 Nov;33(11):1381-1389. doi: 10.1007/s00380-018-1179-4. Epub 2018 Apr 30.

PMID:
29713820
4.

The Use of Electronic Medical Record Data to Analyze the Association Between Atrial Fibrillation and Birth Month.

Matsuda K, Park K, Tatsumi H, Kitada R, Yoshiyama M.

Online J Public Health Inform. 2017 Dec 31;9(3):e199. doi: 10.5210/ojphi.v9i3.7864. eCollection 2017.

5.

Impact of simple electrocardiographic markers as predictors for deterioration of left ventricular function in patients with frequent right ventricular apical pacing.

Hayashi Y, Takagi M, Kakihara J, Sakamoto S, Tatsumi H, Doi A, Iwata S, Sugioka K, Yoshiyama M.

Heart Vessels. 2018 Mar;33(3):299-308. doi: 10.1007/s00380-017-1052-x. Epub 2017 Sep 26.

PMID:
28952029
6.

Radiofrequency catheter ablation for treatment of premature ventricular contractions triggering ventricular fibrillation from the right ventricular outflow tract in a patient with early repolarization syndrome.

Kakihara J, Takagi M, Hayashi Y, Tatsumi H, Doi A, Yoshiyama M.

HeartRhythm Case Rep. 2016 Apr 21;2(4):342-346. doi: 10.1016/j.hrcr.2016.04.001. eCollection 2016 Jul. No abstract available.

7.

Incidence and predictors of silent cerebral thromboembolic lesions after catheter ablation for atrial fibrillation in patients treated with direct oral anticoagulants.

Doi A, Takagi M, Kakihara J, Hayashi Y, Tatsumi H, Fujimoto K, Sugioka K, Yoshiyama M.

Heart Vessels. 2017 Oct;32(10):1227-1235. doi: 10.1007/s00380-017-0985-4. Epub 2017 May 2.

PMID:
28466408
8.

A case of unexpected early battery depletion caused by lithium cluster formation in implantable cardioverter-defibrillator.

Hayashi Y, Takagi M, Kakihara J, Tatsumi H, Atsushi D, Yoshiyama M.

J Cardiol Cases. 2017 Apr 15;15(6):184-186. doi: 10.1016/j.jccase.2017.02.007. eCollection 2017 Jun.

9.

Utility of 12-lead and signal-averaged Holter electrocardiograms after pilsicainide provocation for risk stratification in Brugada syndrome.

Kakihara J, Takagi M, Hayashi Y, Tatsumi H, Doi A, Yoshiyama M.

Heart Vessels. 2017 Sep;32(9):1151-1159. doi: 10.1007/s00380-017-0973-8. Epub 2017 Mar 31.

PMID:
28364267
10.

Long RP' Tachycardia With Unusual Entrainment Responses: What Is the Mechanism?

Doi A, Takagi M, Fujimoto K, Kakihara J, Hayashi Y, Tatsumi H, Yoshiyama M.

J Cardiovasc Electrophysiol. 2016 Oct;27(10):1242-1244. doi: 10.1111/jce.12987. Epub 2016 May 16. No abstract available.

PMID:
27090609
11.

Utility of T-wave alternans during night time as a predictor for ventricular fibrillation in patients with Brugada syndrome.

Sakamoto S, Takagi M, Tatsumi H, Doi A, Sugioka K, Hanatani A, Yoshiyama M.

Heart Vessels. 2016 Jun;31(6):947-56. doi: 10.1007/s00380-015-0692-y. Epub 2015 May 20.

PMID:
25989739
12.

Platypnea-orthodeoxia diagnosed by sitting transesophageal echocardiography.

Nakahira A, Matsumura Y, Tatsumi H, Sasaki Y, Hirai H, Hanatani A, Muro T, Yoshiyama M, Suehiro S.

Ann Thorac Surg. 2010 Apr;89(4):1284-6. doi: 10.1016/j.athoracsur.2009.08.050.

PMID:
20338360
13.

Conduction delay in right ventricle as a marker for identifying high-risk patients with Brugada syndrome.

Doi A, Takagi M, Maeda K, Tatsumi H, Shimeno K, Yoshiyama M.

J Cardiovasc Electrophysiol. 2010 Jun 1;21(6):688-96. doi: 10.1111/j.1540-8167.2009.01677.x. Epub 2009 Dec 28.

PMID:
20050961
14.

A predictor of positive drug provocation testing in individuals with saddle-back type ST-segment elevation.

Shimeno K, Takagi M, Maeda K, Tatsumi H, Doi A, Nakagawa E, Yoshiyama M.

Circ J. 2009 Oct;73(10):1836-40. Epub 2009 Sep 7.

15.

Usefulness of multichannel Holter ECG recording in the third intercostal space for detecting type 1 Brugada ECG: comparison with repeated 12-lead ECGs.

Shimeno K, Takagi M, Maeda K, Tatsumi H, Doi A, Yoshiyama M.

J Cardiovasc Electrophysiol. 2009 Sep;20(9):1026-31. doi: 10.1111/j.1540-8167.2009.01490.x. Epub 2009 May 12.

PMID:
19470036
16.

The effects of nifekalant hydrochloride on the QT dispersion after direct-current defibrillation.

Maeda K, Takagi M, Tatsumi H, Nakagawa E, Yoshiyama M.

Osaka City Med J. 2008 Jun;54(1):11-9.

PMID:
18819261
17.
18.

Approach to the asymptomatic patients with Brugada syndrome.

Takagi M, Tatsumi H, Yoshiyama M.

Indian Pacing Electrophysiol J. 2007 Apr 1;7(2):73-6.

19.

Risk stratification in patients with Brugada syndrome: analysis of daily fluctuations in 12-lead electrocardiogram (ECG) and signal-averaged electrocardiogram (SAECG).

Tatsumi H, Takagi M, Nakagawa E, Yamashita H, Yoshiyama M.

J Cardiovasc Electrophysiol. 2006 Jul;17(7):705-11.

PMID:
16836663

Supplemental Content

Loading ...
Support Center